Structure

Physi-Chem Properties

Molecular Weight:  488.28
Volume:  512.888
LogP:  4.007
LogD:  3.068
LogS:  -4.687
# Rotatable Bonds:  10
TPSA:  88.13
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.209
Synthetic Accessibility Score:  5.611
Fsp3:  0.679
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.68
MDCK Permeability:  8.032945333980024e-05
Pgp-inhibitor:  0.991
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.223
30% Bioavailability (F30%):  0.066

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.172
Plasma Protein Binding (PPB):  86.34703063964844%
Volume Distribution (VD):  2.715
Pgp-substrate:  13.654189109802246%

ADMET: Metabolism

CYP1A2-inhibitor:  0.046
CYP1A2-substrate:  0.08
CYP2C19-inhibitor:  0.164
CYP2C19-substrate:  0.597
CYP2C9-inhibitor:  0.282
CYP2C9-substrate:  0.059
CYP2D6-inhibitor:  0.032
CYP2D6-substrate:  0.144
CYP3A4-inhibitor:  0.773
CYP3A4-substrate:  0.54

ADMET: Excretion

Clearance (CL):  3.294
Half-life (T1/2):  0.125

ADMET: Toxicity

hERG Blockers:  0.003
Human Hepatotoxicity (H-HT):  0.86
Drug-inuced Liver Injury (DILI):  0.941
AMES Toxicity:  0.987
Rat Oral Acute Toxicity:  0.926
Maximum Recommended Daily Dose:  0.762
Skin Sensitization:  0.508
Carcinogencity:  0.684
Eye Corrosion:  0.27
Eye Irritation:  0.12
Respiratory Toxicity:  0.952

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC268462

Natural Product ID:  NPC268462
Common Name*:   ZORWLQPVCJDDHT-SAGQBFQWSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  ZORWLQPVCJDDHT-SAGQBFQWSA-N
Standard InCHI:  InChI=1S/C28H40O7/c1-9-17(4)10-12-27(8)18(5)11-13-28-22(14-21(15-23(27)28)34-24(31)16(2)3)25(32-19(6)29)35-26(28)33-20(7)30/h9-10,14,16,18,21,23,25-26H,1,11-13,15H2,2-8H3/b17-10+/t18-,21+,23+,25+,26-,27-,28-/m1/s1
SMILES:  C=C/C(=C/C[C@]1(C)[C@H](C)CC[C@@]23C(=C[C@@H](C[C@@H]12)OC(=O)C(C)C)[C@@H](OC(=O)C)O[C@H]3OC(=O)C)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24957 Bucida buceras Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[12542360]
NPO28183 Cymbopogon flexuosus Species Poaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28183 Cymbopogon flexuosus Species Poaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28736 Wedelia paludosa Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28113 Oria flava n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO14464 Oxalis triangularis Species Oxalidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28353 Schizanthus pinnatus Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28235 Heimia montana Species Lythraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11029 Bessera tenuiflora Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28564 Pterorhachis zenkeri Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28411 Hedysarum setigerum Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24957 Bucida buceras Species Combretaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28183 Cymbopogon flexuosus Species Poaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC268462 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC268462 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data